PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024,...
5 days ago

Here is how Boston Scientific (BSX) and Canopy Growth Corporation (CGC) have performed compared to their sector so far this year.
21 hours ago

Boston Scientific exceeded profit and sales forecasts on demand for its cardiovascular devices.
5 days ago

Shares of Boston Scientific were trading higher after the medical-device company topped quarterly estimates and issued strong guidance.
5 days ago

This is the most transformational product that I've seen in my career with the company,” CEO Mike Mahoney said on Boston Scientific's...
4 days ago

Sales of cardiovascular products rose 15.9% in the quarter, helping Boston Scientific beat estimates.
5 days ago

Boston Scientific released its 2023 Performance Report highlighting the company's actions to improve patient outcomes while prioritizing environmental,...
22 hours ago

Boston Scientific has solidified its footing as one of three major cardiac device makers and significantly improved its innovation and operational chops.
5 days ago

The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's device used to block blood flow during...
2 weeks ago

Boston Scientific CEO Mike Mahoney says Farapulse, the company's pulsed field ablation (PFA) system, is the most transformational product he...
5 days ago